Hirota Masahiko, Shimada Shinya, Yamamoto Kenichiro, Tanaka Eiji, Sugita Hiroki, Egami Hiroshi, Ogawa Michio
Department of Gastroenterological Surgery, Kumamoto University, Honjo, Kumamoto-city, Japan.
JOP. 2005 Mar 10;6(2):143-51.
In pancreatic cancer, even for patients who have undergone curative resection (R0), survival analysis has revealed a poor survival rate due to cancer recurrence. Because the operation itself might have caused the dissemination of these cancer cells, the no-touch isolation technique and extensive intraoperative peritoneal lavage may be a potential operative procedure for improving the outcome.
Eight patients treated by the no-touch isolation technique were compared with 10 patients treated using conventional techniques.
Cancer cell detection rates in the portal venous blood, frequency of recurrence, and survival rate. We also analyzed the lymphatic fluid squeezed from the resected cancerous pancreatic tissue.
In 5 out of 10 cases (50%) in the conventional procedure group, CEA mRNA was identified in the portal blood after tumor manipulation, while only 1 out of 8 cases (13%) in the no-touch isolation technique group was positive for portal CEA mRNA. All lymphatic fluid samples squeezed from the resected cancerous pancreatic tissue were positive (8/8) for CEA mRNA. The recurrence rate was 90% (9/10) in the conventional procedure group, and 38% (3/8) in the no-touch isolation technique group (P=0.043). In the conventional procedure group, hepatic metastasis, local recurrence, peritoneal dissemination, and extraabdominal recurrence were identified in 6 (60%), 4 (40%), 4 (40%), and 2 patients (20%), respectively. On the other hand, among the no-touch isolation technique group, recurrence was identified in 1 (13%), 1 (13%), 0 (0%), and 1 patient (13%), respectively. There was no peritoneal dissemination along with the decreased hepatic recurrence rate. Mean (+/-SEM) survival time was 21.2+/-5.8 months for the conventional procedure group and 41.5+/-5.6 months for the no-touch isolation technique group (P=0.018). The 3-year survival rate was 12.5+/-11.5% for the conventional procedure group and 75.0+/-21.7% for the no-touch isolation technique group.
This study presented the potential of cancer dissemination during the intraoperative manipulation of tumors and its contribution to cancer recurrence, as well as the significance of the no-touch isolation technique and extensive intraoperative peritoneal lavage for pancreatic cancer surgery.
在胰腺癌中,即使是接受了根治性切除(R0)的患者,生存分析显示由于癌症复发,生存率仍很低。由于手术本身可能导致这些癌细胞的播散,非接触隔离技术和广泛的术中腹腔灌洗可能是改善预后的一种潜在手术方法。
将8例采用非接触隔离技术治疗的患者与10例采用传统技术治疗的患者进行比较。
门静脉血中癌细胞检测率、复发频率和生存率。我们还分析了从切除的癌性胰腺组织中挤出的淋巴液。
在传统手术组的10例患者中有5例(50%)在肿瘤操作后门静脉血中检测到癌胚抗原(CEA)信使核糖核酸(mRNA),而非接触隔离技术组的8例患者中只有1例(13%)门静脉CEA mRNA呈阳性。从切除的癌性胰腺组织中挤出的所有淋巴液样本CEA mRNA均为阳性(8/8)。传统手术组的复发率为90%(9/10),非接触隔离技术组为38%(3/8)(P = 0.043)。在传统手术组中,肝转移、局部复发、腹腔播散和腹外复发分别在6例(60%)、4例(40%)、4例(40%)和2例患者(20%)中发现。另一方面,在非接触隔离技术组中,复发分别在1例(13%)、1例(13%)、0例(0%)和1例患者(13%)中发现。随着肝复发率的降低,没有腹腔播散。传统手术组的平均(±标准误)生存时间为21.2±5.8个月,非接触隔离技术组为41.5±5.6个月(P = 0.018)。传统手术组的3年生存率为12.5±11.5%,非接触隔离技术组为75.0±21.7%。
本研究揭示了肿瘤术中操作过程中癌症播散的可能性及其对癌症复发的影响,以及非接触隔离技术和广泛的术中腹腔灌洗在胰腺癌手术中的重要性。